CAH Cardinal Health

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in 46 countries and approximately 48,000 employees globally, Cardinal Health is essential to care.
Company profile
Ticker
CAH
Exchange
Website
CEO
Michael Kaufmann
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Mckesson • Amerisource Bergen • Herbalife Nutrition • Nu Skin Enterprises • PetIQ • Merion • Trxade • Cosmos • Can B • Mu Yan Technology ...
Former names
CARDINAL DISTRIBUTION INC
SEC CIK
Corporate docs
IRS number
310958666
CAH stock data
()
Press releases
Cardinal Health Launches Navista™ TS to Help Oncology Practices Improve Patient Care, Lower Costs and Drive Success in Value-Based Care
7 Apr 21
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2021 on May 6
30 Mar 21
Cardinal Health Partners with FourKites to Build Cognitive Supply Chain
29 Mar 21
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
12 Mar 21
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
12 Mar 21
Calendar
5 Feb 21
12 Apr 21
30 Jun 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Jun 20 | Jun 19 | Jun 18 | Jun 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from company earnings reports.
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 21 | Mayer Jessica L | Common Shares | Payment of exercise | Dispose F | No | No | 57.35 | 911 | 52.25K | 11,705 |
15 Mar 21 | Mayer Jessica L | Common Shares | Payment of exercise | Dispose F | No | No | 57.35 | 911 | 52.25K | 48,166 |
26 Feb 21 | Mayer Jessica L | Common Shares | Sell | Dispose S | No | No | 51.53 | 3,500 | 180.36K | 12,616 |
15 Feb 21 | Brian S Rice | Common Shares | Payment of exercise | Dispose F | No | No | 51.86 | 1,353 | 70.17K | 25,934 |
11 Feb 21 | Patricia M English | Common Shares | Sell | Dispose S | No | No | 51.98 | 3,291 | 171.07K | 6,085 |
Institutional ownership Q4 2020
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
83.8% owned by funds/institutions
13F holders |
Current |
---|---|
Total holders | 754 |
Opened positions | 111 |
Closed positions | 78 |
Increased positions | 263 |
Reduced positions | 258 |
13F shares |
Current |
---|---|
Total value | 13.41B |
Total shares | 246.17M |
Total puts | 2.11M |
Total calls | 1.66M |
Total put/call ratio | 1.3 |
Largest owners |
Shares | Value |
---|---|---|
Vanguard | 35.71M | $1.91B |
BLK Blackrock | 24.86M | $1.33B |
STT State Street | 18.2M | $983.41M |
MCQEF Macquarie | 12.1M | $647.82M |
TROW T. Rowe Price | 9.01M | $482.34M |
FMR | 6.25M | $334.98M |
BK Bank Of New York Mellon | 5.03M | $269.32M |
Geode Capital Management | 4.95M | $264.66M |
American Century Companies | 4.44M | $237.91M |
NTRS Northern Trust | 3.9M | $209.1M |
Financial report summary
?Competition
Owens & Minor • Merit Medical Systems • Alpha Pro Tech • Actavis • Omnicell • Mckesson • Impax Laboratories • Allscripts Healthcare Solutions • Amerisource Bergen • Vycor MedicalContent analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
actuarial, auto, carryback, dismissed, matter, pertaining, prejudice, refund, repayment, sought, statutory, taxable, USAO
Financial reports
10-Q
2021 Q2
Quarterly report
5 Feb 21
10-Q
2021 Q1
Quarterly report
5 Nov 20
10-K
2020 FY
Annual report
13 Aug 20
10-Q
2020 Q3
Quarterly report
11 May 20
10-Q
2020 Q2
Quarterly report
6 Feb 20
10-Q
2020 Q1
Quarterly report
7 Nov 19
10-K
2019 FY
Annual report
20 Aug 19
10-Q
2019 Q3
Quarterly report
9 May 19
10-Q
2019 Q2
Quarterly report
7 Feb 19
10-Q
2019 Q1
Quarterly report
8 Nov 18
Current reports
8-K
Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
8 Apr 21
8-K
Departure of Directors or Certain Officers
5 Apr 21
8-K
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
12 Mar 21
8-K
Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021
5 Feb 21
8-K/A
Departure of Directors or Certain Officers
9 Nov 20
8-K
Cardinal Health Reports First Quarter Fiscal 2021 Results
5 Nov 20
8-K
Departure of Directors or Certain Officers
31 Aug 20
8-K
Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2020
6 Aug 20
8-K
Departure of Directors or Certain Officers
26 Jun 20
8-K
Cardinal Health Reports Third Quarter Results for Fiscal Year 2020
11 May 20
Registration and prospectus
S-8
Registration of securities for employees
20 Aug 19
S-3ASR
Automatic shelf registration
20 Aug 19
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
10 Aug 17
S-8
Registration of securities for employees
9 Aug 17
424B2
Prospectus for primary offering
4 Jun 17
FWP
Free writing prospectus
1 Jun 17
424B2
Prospectus for primary offering
31 May 17
S-3ASR
Automatic shelf registration
6 Feb 17
Proxies
PX14A6G
Letter to shareholders
23 Oct 20
PX14A6G
Letter to shareholders
19 Oct 20
DEFA14A
Additional proxy soliciting materials
23 Sep 20
DEF 14A
Definitive proxy
23 Sep 20
PRE 14A
Preliminary proxy
8 Sep 20
PX14A6G
Letter to shareholders
4 Nov 19
PX14A6G
Letter to shareholders
4 Oct 19
DEFA14A
Additional proxy soliciting materials
20 Sep 19
DEF 14A
Definitive proxy
20 Sep 19
PX14A6G
Letter to shareholders
18 Oct 18
Other
SD
Conflict minerals disclosure
29 May 20
SD
Conflict minerals disclosure
30 May 19
SD
Conflict minerals disclosure
30 May 18
NO ACT
No action letter
7 Sep 17
NO ACT
No action letter
3 Aug 17
NO ACT
No action letter
2 Aug 17
SD
Conflict minerals disclosure
30 May 17
NO ACT
No action letter
19 Jul 16
SD
Conflict minerals disclosure
30 May 16
SD
Conflict minerals disclosure
28 May 15
Ownership
4/A
CARDINAL HEALTH / Jessica L Mayer ownership change
7 Apr 21
4
CARDINAL HEALTH / Jessica L Mayer ownership change
16 Mar 21
4
CARDINAL HEALTH / Jessica L Mayer ownership change
1 Mar 21
4
CARDINAL HEALTH / Brian S Rice ownership change
16 Feb 21
SC 13G/A
CARDINAL HEALTH / MACQUARIE ownership change
12 Feb 21
4
CARDINAL HEALTH / Patricia M English ownership change
12 Feb 21
SC 13G/A
CARDINAL HEALTH / VANGUARD ownership change
10 Feb 21
SC 13G
CARDINAL HEALTH / STATE STREET ownership change
5 Feb 21
SC 13G/A
CARDINAL HEALTH / BlackRock ownership change
28 Jan 21
4
CARDINAL HEALTH / DEAN A SCARBOROUGH ownership change
19 Jan 21
Patents
APP
Utility
Stent Attachment and Deployment Mechanism
1 Apr 21
A stent attachment and deployment mechanism is utilized to prevent the distal end of an endoprosthesis comprising fixation barbs or other fixation mechanism from deploying prior to the remaining sections of the fixation device.
GRANT
Utility
Stent delivery catheter with convertible living-hinge for slow to fast retraction
23 Feb 21
Various embodiments for a stent delivery device that utilizes a lost motion technique via a living connected to two cantilever arms for slow retraction of an outer sheath and an actuator member coupled to the two arms for fast retraction of the outer sheath during delivery of a self-expanding implantable device such as a stem or stent graft.
GRANT
Utility
Remote monitoring of absorbent article
2 Feb 21
In one example, a sensor system of a patient monitoring system includes a voiding sensor that includes an electrical circuit configured to be transitioned from a first impedance state to a second impedance state in response to a voiding event in an absorbent region of an absorbent article worn by a patient.
GRANT
Utility
Systems, methods and devices for producing, manufacturing and control of radiopharmaceuticals
2 Feb 21
Systems, methods, and devices for generating radionuclides for use in production of radiopharmaceuticals; synthesizing the radionuclides generated and removing any unwanted products; measuring the quantity and activity level of the synthesized radionuclides; distributively delivering the radionuclides in appropriate quantities to modular cassette synthesis units in a modular cassette subsystem for contemporaneous/parallel production of radiopharmaceutical output and that allow reuse and/or quick, safe, and disposable replacement of portions of the subsystem; delivering non-radionuclide components to the modular cassette synthesis units as part of production of radiopharmaceutical output; measuring the quantity and activity level of each stream of radiopharmaceutical output; purifying the radiopharmaceutical output; dispensing individual doses in sterile vial(s); automatically producing labeling and dose related information; performing automated quality control on extracted samples of produced radiopharmaceutical output; and providing software and hardware controls for overall and sub-portion operation for optional remote data collection, communication, and/or control.
GRANT
Utility
Stent delivery catheter system with slow speed control via pin and slot with fast speed control tab
19 Jan 21
Various embodiments are described for a stent delivery device that utilizes a push button using a slot and pin on a shuttle with a rack for slow retraction of the outer sheath as well as a flanged member connected to the outer sheath for fast retraction of the outer sheath during delivery of a self-expanding implantable device such as a stent or stent graft.
Transcripts
2021 Q2
Earnings call transcript
5 Feb 21
2020 Q3
Earnings call transcript
5 Nov 20
2020 Q4
Earnings call transcript
6 Aug 20
2020 Q3
Earnings call transcript
11 May 20
2020 Q2
Earnings call transcript
6 Feb 20
2020 Q1
Earnings call transcript
7 Nov 19
2019 Q4
Earnings call transcript
8 Aug 19
2019 Q3
Earnings call transcript
9 May 19
2019 Q2
Earnings call transcript
7 Feb 19
2019 Q1
Earnings call transcript
8 Nov 18
Reddit threads
Weekly Recap - Dividend Aristocrats
10 Apr 21
Weekly Update - Dividend Aristocrats
1 Apr 21
Monthly update, 32% more dividends since December.
31 Mar 21
Daily Discussion Thread - March 31st, 2021
31 Mar 21
Tell me if what I’ve done is good, bad, or ugly.
30 Mar 21
Daily Discussion Thread - March 30th, 2021
30 Mar 21
Daily Discussion Thread - March 29th, 2021
29 Mar 21
Weekly Recap - Dividend Aristocrats
26 Mar 21
Overcomplicating Dividend Portfolio?
23 Mar 21
How is it even worth it to study patterns and technical analysis when everything can just be super random
22 Mar 21